PRINCE HARRY LEAVES AFRICAN PARKS BOARD AFTER CHARITY ADMITTED RANGERS COMMITTED HUMAN RIGHTS ABUSES. (PHOTO).

-
Image
 Prince Harry leaves African Parks board after charity admitted rangers committed human rights abuses Prince Harry has left the board of African Parks after nearly a decade with the conservation charity, a year after the organization acknowledged that some of its rangers had committed human rights abuses. A spokesperson for Harry, 41, confirmed his departure while emphasizing that his work in African conservation will continue. “The Duke is proud of his 10 years with African Parks and fully supports the ongoing strengthening of its Board,” the spokesperson said. “His commitment to conservation in Africa continues, and he remains a supporter of African Parks’ mission.” Harry first partnered with African Parks in 2016 and became president of the organization the following year. He was appointed to its board of directors in 2023. His departure comes after African Parks commissioned an independent investigation into allegations that rangers had r@ped, beaten and tortured Indigenous peo...
Post a Comment

NAFDAC NOTIFIES THE PUBLIC OF FALSIFIED TYPE 1 AND TYPE 2 BATCHES OF POSTINOR-2 (LEVONORGESTREL 0.75MG) PRODUCT IN CIRCULATION. (PHOTOS). #PRESS RELEASE

-


 Public Alert No. 027/2025.

Alert on confirmed counterfeit Postinor-2 (Levonorgestrel 0.75mg) in Nigeria

NAFDAC notifies the public of falsified Type 1 and Type 2 batches of POSTINOR-2 (Levonorgestrel 0.75mg) product in circulation. A report was received from the Marketing Authorisation Holder @SFHNigeria confirming that they did not import the product batch in question.


Product details:

•On the fake product, the PIN verification sticker has a smaller font size and misspells “Verify” as “Veify”. The original sticker uses a larger, clearer font.

•On the fake pack, the word “Distributed in Nigeria” is wrongly spelt as “Distnibuted in Nigeria”

Risk Statement

Due to the possible presence of harmful or substandard ingredients, incorrect dosages of levonorgestrel, and unsafe manufacturing practices, falsified Postinor-2 (Levonorgestrel 0.75mg) poses serious risks to individual health and public safety.

These risks include contraceptive failure, toxic contamination, unpredictable side effects, delayed or missed access to genuine emergency contraception, and long-term reproductive health complications.

Counterfeit medicines may also contain unknown substances that can cause allergic reactions, organ damage, or even death. Patients are strongly advised to obtain Postinor-2 only from verified pharmacies or licensed healthcare providers.

Healthcare professionals and consumers are advised to report any suspicion of the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office, call 0800-162-3322 or send an email to sf.alert@nafdac.gov.ng.

More photos below. 





Comments

Post a Comment